# Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height

> **NCT00396474** · — · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Infant, Small for Gestational Age

## Interventions

- **OTHER:** post GH treatment observational study

## Key facts

- **NCT ID:** NCT00396474
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-01
- **Primary completion:** —
- **Final completion:** 2012-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study design no longer relevant and no patients were recruited.
- **Last updated:** 2015-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00396474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00396474, "Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00396474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*